fosinopril has been researched along with Cardiac Failure in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (57.89) | 18.2507 |
| 2000's | 15 (39.47) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Abboa-Offei, BE; Asaad, MM; Bednarz, MS; Chao, S; Cheung, HS; Cimarusti, MP; Dejneka, T; Fox, M; Mathers, PD; Misra, RN; Robl, JA; Ryono, DE; Schaeffer, TR; Seymour, AA; Simpkins, LM; Slusarchyk, WA; Smith, PL; Stevenson, J; Stratton, L; Sun, CQ; Trippodo, NC | 1 |
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Ma, Q; Ning, Y; Sun, M; Wu, S; Yang, L; Yang, T | 1 |
| Tereshchenko, SN; Zhirov, IV | 1 |
| Bicket, DP | 1 |
| Karkishchenko, NN; Makliakov, IuS; Sarbilina, IV | 1 |
| Lai, KN; Lam, KY; Leung, JC; Li, PS; Wing-Hon Lai, K; Yu, CM | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N | 1 |
| Berezin, AE | 1 |
| Cheng, XS; He, JG; Li, L; Li, YH; Liu, GZ; Ruan, YM; Wu, ZJ | 1 |
| Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Gao, J; He, H; Ma, L; Wang, P; Wang, W; Wu, H; Zhang, H | 1 |
| Aurigemma, GP; Douglas, PS; Katz, SE; Litwin, SE; Lorell, BH; Weinberg, EO | 1 |
| Blumenthal, M; Brown, EJ; Chew, PH; Gelperin, K; Ilgenfritz, JP; MacLean, A | 1 |
| Binder, SB | 1 |
| Ford, NF; Fulmor, IE; Hui, KK; Natarajan, C; Smith, RA | 1 |
| Delaney, C; Garland, WT; Kostis, JB; Liao, WC; Norton, J | 1 |
| Blumenthal, M; Erhardt, L; Gelperin, K; Ilgenfritz, J; MacLean, A | 1 |
| Bie, P; Emmeluth, C; Galatius-Jensen, S; Haunsø, S; Kastrup, J; Wroblewski, H | 1 |
| Berger, R; Dukat, A; Frey, B; Hülsmann, M; Koller-Strametz, J; Kos, T; Pacher, R; Stanek, B | 1 |
| Himeno, H; Hiroto, S; Minamisawa, K; Naruse, M; Shionoiri, H; Takasaki, I; Ueda, S | 1 |
| Coukell, A; Davis, R; McTavish, D | 1 |
| Giannattasio, C; Grassi, G; Mancia, G | 1 |
| Szucs, TD | 1 |
| Deedwania, PC | 1 |
| Blumenthal, M | 1 |
| Ambrosioni, E; Borghi, C; Collatina, S; Magnani, B; Marino, P; Zardini, P | 1 |
| Chati, Z; Guest, M; Plat, F; Zannad, F | 1 |
| Galatius, S; Haunsø, S; Kastrup, J; Nørgaard, T; Sørensen, V; Wroblewski, H | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Caspi, A; Greenbaum, R; Liao, WC; Mangold, B; Nouriel, H; O'Grady, P; Paz, R; Sclarovsky, S; Yee, KF; Zucchelli, P | 1 |
| Cukon, S; Ennezat, PV; Hammer, A; Infeld, J; Jorde, UP; Le Jemtel, TH; Lisker, J; Sonnenblick, EH; Suryadevara, V | 1 |
| Blumenthal, M; Deitchman, D; Eni, JS; Gelperin, K; Ilgenfritz, JP; Sharma, S | 1 |
| Ayan, F; Eryonucu, B; Keser, N; Koldas, L; Sirmaci, A | 1 |
| Bonnet, F; Burrell, LM; Cao, Z; Cooper, ME; Gilbert, RE; Tikkanen, I | 1 |
| Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y | 1 |
9 review(s) available for fosinopril and Cardiac Failure
| Article | Year |
|---|---|
[Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Fosinopril; Heart Failure; Humans; Renal Insufficiency; Sympathetic Nervous System; Syndrome; Treatment Outcome | 2009 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
ACE inhibitors: review of four new agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines | 1993 |
Fosinopril. Clinical pharmacokinetics and clinical potential.
Topics: Absorption; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1997 |
Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Fosinopril; Heart Failure; Hemodynamics; Humans | 1997 |
Treatment of heart failure with fosinopril: an angiotensin converting enzyme inhibitor with a dual and compensatory route of excretion.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Controlled Clinical Trials as Topic; Fosinopril; Heart Failure; Hemodynamics; Humans; Kidney; Liver; Matched-Pair Analysis; Pressoreceptors; Renin-Angiotensin System; Stroke Volume; Survival Rate; Sympathetic Nervous System | 1997 |
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
The progression from hypertension to heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged | 1997 |
Treatment of congestive heart failure: experience with fosinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Enalaprilat; Exercise Tolerance; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Diseases; Lisinopril; Male | 1997 |
13 trial(s) available for fosinopril and Cardiac Failure
| Article | Year |
|---|---|
[Plasma tissue factor and serum angiotensin II and the therapeutic effect of different dosages of fosinopril on chronic heart failure].
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Thromboplastin | 2009 |
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group.
Topics: Aged; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Female; Fosinopril; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Prospective Studies | 1995 |
Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Female; Fosinopril; Heart Failure; Humans; Injections, Intravenous; Male; Matched-Pair Analysis; Middle Aged; Prodrugs | 1995 |
Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Fosinopril; Heart Failure; Hemodynamics; Humans; Prospective Studies; Treatment Outcome | 1995 |
Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Echocardiography; Endothelins; Exercise Test; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Regression Analysis | 1996 |
Effects of atenolol as add-on therapy to fosinopril in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Stroke Volume; Ventricular Function, Left | 1997 |
Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Follow-Up Studies; Fosinopril; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator | 1998 |
Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Fosinopril; France; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome | 1998 |
Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fosinopril; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Pressoreceptors; Regional Blood Flow; Time Factors; Vascular Resistance | 1999 |
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalaprilat; Female; Fosinopril; Heart Failure; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Time Factors | 2000 |
The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies | 1999 |
Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged | 2001 |
16 other study(ies) available for fosinopril and Cardiac Failure
| Article | Year |
|---|---|
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Enzyme Inhibitors; Heart Failure; Hypertension; Macaca fascicularis; Neprilysin; Pyridines; Rats; Renin; Sodium; Thiazepines | 1997 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
[Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Fosinopril; Glucose; Heart Failure; Hemodynamics; Humans; Immunologic Factors; Male; Oligopeptides; Ramipril; Time Factors | 2003 |
Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aquaporin 2; Aquaporins; Drug Therapy, Combination; Fosinopril; Gene Expression; Heart Failure; Kidney Cortex; Kidney Medulla; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2004 |
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Clinical Trials as Topic; Europe; Fosinopril; Heart Failure; Humans; Meta-Analysis as Topic; Propanolamines | 2004 |
[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Data Interpretation, Statistical; Echocardiography; Fosinopril; Heart Failure; Humans; Immunoenzyme Techniques; Middle Aged; Natriuretic Peptide, Brain; Radioimmunoassay; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
[Changes of collagen expression of pulmonary arteries and heart ventricles and intervention of fosinopril and losartan in rats with heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Female; Fosinopril; Heart Failure; Heart Ventricles; Losartan; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2004 |
Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Carbazoles; Cardiomegaly; Carvedilol; Fosinopril; Heart Failure; Lung; Male; Myocardium; Propanolamines; Protein Kinase C-epsilon; Proteomics; Rats; Rats, Sprague-Dawley; Signal Transduction | 2006 |
Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Echocardiography; Fosinopril; Heart Failure; Hemodynamics; Hypertension; Male; Rats; Rats, Wistar; Systole; Time Factors; Ventricular Function, Left | 1995 |
Invasive pharmacodynamics of fosinopril in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Chromatography, High Pressure Liquid; Female; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure; Renin | 1995 |
[Fosinopril in the cardiovascular management of elderly patients].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertension, Renal; Male | 1996 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Fosinopril; Heart Failure; Humans; Lisinopril; Male; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Treatment Failure; Valine; Valsartan | 2000 |
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Creatinine; Disease Models, Animal; Fosinopril; Glomerular Filtration Rate; Heart Failure; Hypertension, Renal; Kidney; Male; Nephrectomy; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Thiazepines; Urea | 2001 |
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines | 2001 |
Three new ACE inhibitors for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Bridged Bicyclo Compounds; Drug Interactions; Fosinopril; Heart Failure; Humans; Hypertension; Prodrugs; Proline; Ramipril | 1991 |